That NB compound treatment sensitizes breast cancer cells to ferroptosis inducers such as DHA and JKE1674 indicates that their combined use might be efficacious in improving the effectiveness of breast cancer therapy and possibly also the treatment of other types of cancer driven by high levels of FOXM1. The gene discussed is FOXM1; the disease is breast carcinoma.